NextPlat's ClearMetrx Subsidiary to Launch Artificial Intelligence-Powered ClearMetrX 4.0 Software for Modernized Healthcare Analytics and Reporting
PR Newswire HALLANDALE BEACH, Fla., Sept. 23, 2025 Enhanced Software Suite to Feature AI-Assisted Analytics and Insights Designed to Support Greater Efficiency in Healthcare Operations While Driving Improved Patient Adherence and Outcomes HALLANDALE BEACH, Fla., Sept. 23, 2025 /PRNewswire/ -- NextPlat Corp (NASDAQ: NXPL) (NASDAQ: NXPLW) ("NextPlat" or the "Company"), a global consumer products and services company providing healthcare and technology solutions through e-Commerce and retail channels worldwide, today announced that its ClearMetrx subsidiary has commenced late-stage development of ClearMetrX 4.0, the next generation of its proprietary healthcare data analytics and reporting software featuring a full range of artificial intelligence (AI)-enhanced capabilities. ClearMetrX 4.0 is expected to be rolled out internally in Q4, 2025. The Company intends to commercialize the software for new and existing customer deployments in the first half of 2026.
ClearMetrX is a cloud-based, end-to-end reporting platform that streamlines data analytics for physicians, management services organizations (MSOs), 340B entities, and pharmacies, and is actively used across the Company's pharmacies and client network. ClearMetrX 4.0 will integrate an array of AI-powered enhancements into the software, designed to increase its value as a comprehensive decision-support system, enabling a more streamlined way to collect, analyze and operationalize organizational healthcare data. According to Grandview Research, the global AI in healthcare market size was estimated at USD 26.57 billion in 2024 and is projected to reach USD 187.69 billion by 2030, growing at a CAGR of 38.62% from 2025 to 2030. A key factor driving market growth is the increasing demand in the healthcare sector for enhanced efficiency, accuracy, and better patient outcomes. Birute Norkute, Vice President of Healthcare Operations at NextPlat, said, "Since its introduction, ClearMetrX has demonstrated its capabilities to positively impact not only the business of healthcare for us and a growing list of customers, but importantly, support better outcomes through improved patient adherence. With ClearMetrX 4.0, we are honoring our commitment to harness the power of technology such as AI to further improve the efficiency and effectiveness of healthcare to the benefit of all stakeholders." Highlighted features of ClearMetrX 4.0 include: To learn more about ClearMetrX or to request information on how it can meet your needs or to schedule a demonstration, please visit https://www.clearmetrx.com/ For more information about NextPlat, please visit www.NextPlat.com and connect with us on Facebook, LinkedIn and X. About NextPlat Corp Forward-Looking Statements Media and Investor Contact for NextPlat Corp: Michael Glickman SOURCE NextPlat Corp.
Nextplat is a global consumer products and services company providing healthcare and technology solutions through e-Commerce and retail channels worldwide. Through acquisitions, joint ventures, and collaborations, the Company seeks to assist businesses in selling their goods online, domestically, and internationally, allowing customers and partners to optimize their e-Commerce presence and revenue. NextPlat currently operates an e-Commerce communications division offering voice, data, tracking, and IoT products and services worldwide as well as pharmacy and healthcare data management services in the United States through its subsidiary, Progressive Care.
Certain statements in this release constitute forward-looking statements. These statements include the capabilities and success of the Company's business and any of its products, services or solutions. The words "believe," "forecast," "project," "intend," "expect," "plan," "should," "would," and similar expressions and all statements, which are not historical facts, are intended to identify forward-looking statements. These forward-looking statements involve and are subject to known and unknown risks, uncertainties and other factors, including the Company's ability to launch additional e-commerce capabilities for consumer and healthcare products and its ability to grow and expand as intended, any of which could cause the Company to not achieve some or all of its goals or the Company's previously reported actual results, performance (finance or operating), including those expressed or implied by such forward-looking statements. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company's filings with the Securities and Exchange Commission (the "SEC"), copies of which may be obtained from the SEC's website at www.sec.gov. The Company assumes no, and hereby disclaims any, obligation to update the forward-looking statements contained in this press release.
MWGCO, Inc.
917-397-2272
mike@mwgco.net
The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.